Menu Close

Immunotherapy pioneers reveal updated efficacy data of tisagenlecleucel CAR T-cell therapy

Physician-scientists from Children’s Hospital of Philadelphia (CHOP) presented updated efficacy and safety data on Kymriah(R)* (tisagenlecleucel, formerly CTL019) –the first-ever U.S. Food and Drug Administration (FDA) approved personalized CAR T-cell … (본문 전체 12/5/2018 2:21 AM)